IMR Press / CEOG / Volume 41 / Issue 6 / DOI: 10.12891/ceog17332014

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research
Premature ovarian failure: diagnosis and treatment
Show Less
1 Department of Gynecological Endocrinology Poznan University of Medical Sciences, Chyby (Poland)
Clin. Exp. Obstet. Gynecol. 2014, 41(6), 659–661; https://doi.org/10.12891/ceog17332014
Published: 10 December 2014
Abstract

Premature ovarian failure (POF), also known as primary ovarian insufficiency, is diagnosed in the event when primary or secondary amenorrhea and hypoestrogenism with high levels of gonadotropins occur in women before the age of 40. POF, caused by genetic, autoimmune and environmental factors, leads to a decrease in numbers of primordial follicles, accelerated atresia, and impaired follicular function. The diagnosis of POF is an indication for hormonal replacement therapy (HRT), which should be continued until the mean age of menopause in a given population. HRT reduces the intensity of vasomotor symptoms and has a beneficial effect on the central nervous, skeletal, cardiovascular, and urinary-reproductive systems.
Keywords
Premature ovarian failure
Menopause
Hormonal replacement therapy
Share
Back to top